Kisspeptin-10 Research FAQ

These answers are written for a research audience and deliberately avoid any health, dosing, or outcome claims. Kisspeptin-10 is supplied for laboratory research use only and is not for human consumption.

Q: What is Kisspeptin-10? A: Kisspeptin-10 is a synthetic decapeptide corresponding to the shared C-terminal 10-amino-acid sequence found in all bioactive fragments of the KISS1 gene product (kisspeptin-54, -14, -13, and -10), reported to activate the G protein-coupled receptor GPR54 (KISS1R) [1].

Q: What does published research study Kisspeptin-10 for? A: The literature has investigated Kisspeptin-10 in relation to GPR54/KISS1R receptor signaling, luteinizing hormone (LH) pulsatility in men, and reproductive-hormone secretion in men with type 2 diabetes and mild hypogonadism, alongside related human studies of the longer kisspeptin-54 fragment in women's menstrual-cycle physiology, IVF oocyte maturation, and brain imaging [1, 3, 4, 5, 6, 7]. These are studied mechanisms, not established human effects.

Q: Is there human clinical evidence for Kisspeptin-10? A: Yes — more first-in-human dosing data than for many research peptides. A first-in-human study administered intravenous Kisspeptin-10 to healthy men and reported increased LH pulse frequency without observed tachyphylaxis over a 22-hour infusion [3], and a separate study reported increased testosterone and LH in men with type 2 diabetes and mild hypogonadism [4]. No kisspeptin-based compound is FDA-approved.

Q: How does Kisspeptin-10 compare to Kisspeptin-54? A: They share the same bioactive C-terminal decapeptide sequence and both activate GPR54/KISS1R, but they have largely been studied in different contexts — Kisspeptin-10 primarily in men's LH pulsatility and hypogonadism research, and kisspeptin-54 in women's menstrual-cycle physiology, IVF triggering, and neuroimaging research. See Kisspeptin-10 vs Kisspeptin-54: what the research compares.

Q: Does chronic dosing cause tachyphylaxis? A: Research on the related kisspeptin-54 fragment has reported tachyphylaxis (a diminishing hormonal response) with chronic or repeated dosing in some populations, including women with functional hypothalamic amenorrhea, though a separate study found twice-daily dosing over one week did not abolish menstrual cyclicity in women with normal cycles [8]. This is an active area of the published pharmacology literature, not a settled finding for every dosing regimen or population.

Q: How is research-grade Kisspeptin-10 supplied? A: Typically as a lyophilized (freeze-dried) powder for reconstitution in a laboratory setting, accompanied by a Certificate of Analysis confirming HPLC-verified purity.

Q: Can I use Kisspeptin-10? A: Materials described here are for laboratory research only and are not for human consumption. Nothing here is medical advice.